Investor Overview

Development Stage Company

Tissue Genesis has a limited operating history, and has not yet commercialized any products and therefore, has not generated product revenues. To date, the company has focused on development of its BOS platform products and the development of autologous adipose-derived cells for use in various applications, including wound care solutions and endothelialized grafts for vascular applications. The company has been profitable in its early R & D stages due to government contract revenues.

Legislative Action Regarding Hawaii State High-Technology Tax Credits

Hawaii Science & Technology Council Legislative Information

Capitalization

Please contact us for information regarding our capitalization.

Shareholder News:

	January 2010 Shareholder Newsletter
	July 2009 Shareholder Newsletter
	July 2008 Shareholder Newsletter
	September 2007 Shareholder Newsletter
	September 2006 Shareholder Newsletter
	August 2005 Shareholder Newsletter

For more information contact us at:

Tissue Genesis, Inc.
677 Ala Moana Boulevard
Suite 1100
Honolulu, HI 96813

Phone: (808) 539-9331
Fax: (808) 539-9345

Email Tissue Genesis, Inc.